INTRODUCTION
Atrial fibrillation (AF) is the commonest arrhythmia seen in medical practice. It is associated with an increased morbidity and mortality, and its management, particularly that of associated adverse outcomes, is costly. 1 The prevalence of AF increases with age (0.5% of those aged 50-59 years to 8.8% of those aged 80-89 years), as do the associated risks. 2 It is implicated in the aetiology of 33% of strokes in older people. 3 The risk of stroke can be significantly reduced by antiplatelet drugs or anticoagulants, but to benefit from such without knowledge of the patients' histories, their pulse rates or rhythms, or the findings of the fingerprobe device.
This methodology allowed a comparison of a cardiologist's interpretation of the ECG with the AFS instrument results, and thus an analysis of the utility of the AFS as compared to the current gold standard for detecting AF.
RESULTS
A total of 594 patients were tested. The results are expressed as false positives, where the instrument suggested AF but this was not detected on the 12-lead ECG, and as false negatives, where the 12-lead ECG showed AF, but the instrument did not -the 12-lead ECG/cardiologist being the 'gold-standard'. Modifying the index for diagnosis of AF on the AF screening instrument resulted in changes in the test characteristics (Table 1) . To correctly detect all cases of AF (100% sensitivity), a false-positive rate of 8.9% (specificity 91.1%) was obtained. The false positives were accounted for by the presence of ventricular and supraventricular ectopic beats.
DISCUSSION

Summary of main findings
The AFS instrument uses Fourier analysis to derive the spectrum for a perfect sinusoidal waveform. This is used electronically as the baseline template. In sinus rhythm, the variance from that template is zero. The clinical trial results show there is a threshold above which AF is highly likely to be present. As with other clinical tests, varying the diagnostic 'cut-point' alters the test characteristics. These results are based on a single test (or exposure). It would be expected that two or more exposures would further reduce the false-negative rate.
Strengths and limitations of the study
The electronic nature of the instrument allows the testing process to be carried out under minimum supervision in any setting; for example, a GP surgery or pharmacy. It is unlikely that it would perform differently outside a hospital environment. The settings for this study were chosen for pragmatic reasons: these patients were due to have ECG
How this fits in
This article describes an electronic instrument with a high sensitivity and high specificity for detecting atrial fibrillation. It has the potential to deliver a community-based screening programme for atrial fibrillation. Despite high sensitivity and specificity, the instrument is intended for screening and not diagnosing, as it is not intended to replace the gold standard of interpretation of the 12-lead electrocardiogram. recordings as part of their routine hospital management. The prevalence of AF outside hospital is likely to be lower, even in patients of the same age range, and while this would not affect the sensitivity and specificity, the post-test probability would be affected.
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Implications for clinical practice
Until now the cost-effectiveness and efficacy of a routine screening programme has not been shown to have adequate merit over and above opportunistic screening. The application of Wilson and Jungner's long-established criteria for screening programmes to the use of this instrument allows the authors to propose that its use be considered in the early detection of AF in the community setting. 6 It provides a reliable and accurate table-top instrument that allows a low-cost routine screening process leading to a confirmatory ECG.
